cibinqo
pfizer europe ma eeig - abrocitinib - dermatitis, atopic - egyéb bőrgyógyászati készítmények - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
briviact (in italy: nubriveo)
ucb pharma sa - brivaracetam - epilepszia - antiepileptikumok, - a briviact kiegészítő terápiaként szolgál a 16 éves kor feletti felnőtt és serdülőkorú epilepsziában szenvedő másodlagos generalizációval vagy anélküli parciális görcsrohamok kezelésében.
bimzelx
ucb pharma s.a. - bimekizumab - pikkelysömör - immunszuppresszánsok - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - készítmények sebek és fekélyek kezelésére - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
bosentan cipla 62,5 mg filmtabletta
cipla (eu) ltd. - boszentán -
bosentan cipla 125 mg filmtabletta
cipla (eu) ltd. - boszentán -
frisium 10 mg tabletta
sanofi-aventis zrt. - clobazam -
ninlaro
takeda pharma a/s - ixazomib citrátot - myeloma multiplex - daganatellenes szerek - a lenlidomiddal és a dexametazonnal kombinációban szenvedő ninlaro jelzett többszörös mielóma felnőtt betegek kezelésére, akik legalább egy korábbi terápiát kaptak.
ontozry
angelini pharma s.p.a - cenobamate - epilepszia - antiepileptikumok, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.
nasivin classic 0,5 mg/ml tartósítószermentes oldatos orrspray
p&g health germany gmbh - oximetazolin -